Launch of virtual Sanger seminar series

Sanger seminars banner

The Wellcome Sanger Institute is pleased to launch a new series of virtual seminars, showcasing the diversity of genomic research at the Institute aimed at tackling some of the biggest challenges in human health and disease. From mapping all cell types in the human body, to understanding the evolution of cancer and life on Earth, senior scientists and faculty at the Sanger Institute will present the latest developments in their field. 

The virtual seminar series will take place monthly and is freely available and open to all who wish to attend. Further details and joining instructions are available here: Password (case sensitive): Sanger2020

To launch the seminar series, Dr Sarah Teichmann, Head of Cellular Genetics at the Sanger Institute and Co-Founder of the Human Cell Atlas, will speak on Wednesday 15 July, 16:00-17:00 BST. 

Sarah will describe how an international team of scientists is mapping the human body, one cell at a time, to create the Human Cell Atlas (HCA). Sarah will share how the HCA is providing unprecedented understanding of human cells and tissue architecture in health and disease, including reproductive biology, auto-immune disease and COVID-19 infection.

Dr Peter Campbell, Head of Cancer, Ageing and Somatic Mutation at the Sanger Institute, will give the following seminar on 19 August. Peter will discuss somatic mutations, and how researchers are characterising the landscape of mutations in cells to provide insights into normal tissue development and maintenance, cancer evolution, diseases other than cancer, and ageing.

The full programme of seminar speakers will soon be available. 

The current COVID-19 pandemic has resulted in researchers travelling less and attending fewer scientific meetings. However, Sanger scientists remain eager to communicate their science and there is an appetite from the scientific community to hear Sanger’s latest research developments. The virtual seminar series will reach an even more diverse audience, including researchers from countries where travel to scientific meetings can be more difficult.

Dr Julia Wilson, Associate Director of the Wellcome Sanger Institute, said: “We are thrilled to be able to share the latest research from the Sanger Institute in this new virtual seminar series, and celebrate the diversity and culture of our Institute. Sanger is unique in terms of the scale of research we do. The Institute takes a leading role in international research projects, while maintaining a culture of openness. Our researchers drive innovation and the translation of research to solve the challenges facing society. We hope you can join us for this exciting series of seminars.”


The Wellcome Sanger Institute is one of the premier centres of genomic discovery and understanding in the world. It leads ambitious collaborations across the globe to provide the foundations for further research and transformative healthcare innovations.

Wellcome Sanger Institute